WallStreetZenWallStreetZen

NASDAQ: PRCT
Procept Biorobotics Corp Stock

$48.84+2.41 (+5.19%)
Updated Mar 27, 2024
PRCT Price
$48.84
Fair Value Price
$52.15
Market Cap
$2.49B
52 Week Low
$24.83
52 Week High
$52.32
P/E
-21.8x
P/B
8.87x
P/S
14.54x
PEG
N/A
Dividend Yield
N/A
Revenue
$136.19M
Earnings
-$105.90M
Gross Margin
52.2%
Operating Margin
-74.82%
Profit Margin
-77.8%
Debt to Equity
0.44
Operating Cash Flow
-$108M
Beta
1.38
Next Earnings
Apr 25, 2024
Ex-Dividend
N/A
Next Dividend
N/A

PRCT Overview

PROCEPT BioRobotics Corporations is a surgical robotics company advancing solutions in urology. The company offers the AquaBeam Robotic System, an image-guided, surgical robotic system used in minimally invasive urologic surgery, with an initial focus on benign prostatic hyperplasia. It has an install base of 130 AquaBeam Robotic Systems worldwide, 78 of which are in the U.S. PROCEPT BioRobotics was incorporated in 2007 and is headquartered in Redwood City, CA.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PRCT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PRCT ($48.84) is undervalued by 6.36% relative to our estimate of its Fair Value price of $52.15 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PRCT ($48.84) is not significantly undervalued (6.36%) relative to our estimate of its Fair Value price of $52.15 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PRCT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PRCT due diligence checks available for Premium users.

Be the first to know about important PRCT news, forecast changes, insider trades & much more!

PRCT News

Valuation

PRCT fair value

Fair Value of PRCT stock based on Discounted Cash Flow (DCF)
Price
$48.84
Fair Value
$52.15
Undervalued by
6.36%
PRCT ($48.84) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PRCT ($48.84) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PRCT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PRCT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-21.8x
Industry
30.11x
Market
44.45x

PRCT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.87x
Industry
4.1x
PRCT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PRCT's financial health

Profit margin

Revenue
$43.6M
Net Income
-$27.5M
Profit Margin
-63.1%
PRCT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PRCT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$404.7M
Liabilities
$124.0M
Debt to equity
0.44
PRCT's short-term assets ($350.57M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PRCT's short-term assets ($350.57M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PRCT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$24.8M
Investing
-$8.7M
Financing
$2.9M
PRCT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PRCT vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
PRCT$2.49B+5.19%-21.80x8.87x
CNMD$2.47B+3.96%38.16x2.96x
TMDX$2.42B-0.50%-96.26x17.67x
TNDM$2.32B+4.78%-10.29x7.39x
IART$2.72B+3.20%40.98x1.72x

Procept Biorobotics Stock FAQ

What is Procept Biorobotics's quote symbol?

(NASDAQ: PRCT) Procept Biorobotics trades on the NASDAQ under the ticker symbol PRCT. Procept Biorobotics stock quotes can also be displayed as NASDAQ: PRCT.

If you're new to stock investing, here's how to buy Procept Biorobotics stock.

What is the 52 week high and low for Procept Biorobotics (NASDAQ: PRCT)?

(NASDAQ: PRCT) Procept Biorobotics's 52-week high was $52.32, and its 52-week low was $24.83. It is currently -6.65% from its 52-week high and 96.7% from its 52-week low.

How much is Procept Biorobotics stock worth today?

(NASDAQ: PRCT) Procept Biorobotics currently has 50,964,211 outstanding shares. With Procept Biorobotics stock trading at $48.84 per share, the total value of Procept Biorobotics stock (market capitalization) is $2.49B.

Procept Biorobotics stock was originally listed at a price of $41.94 in Sep 15, 2021. If you had invested in Procept Biorobotics stock at $41.94, your return over the last 2 years would have been 16.45%, for an annualized return of 7.91% (not including any dividends or dividend reinvestments).

How much is Procept Biorobotics's stock price per share?

(NASDAQ: PRCT) Procept Biorobotics stock price per share is $48.84 today (as of Mar 27, 2024).

What is Procept Biorobotics's Market Cap?

(NASDAQ: PRCT) Procept Biorobotics's market cap is $2.49B, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Procept Biorobotics's market cap is calculated by multiplying PRCT's current stock price of $48.84 by PRCT's total outstanding shares of 50,964,211.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.